The Swallowing Systems Core team is dedicated to improving the lives of individuals suffering devastating neurodegenerative disease. Through innovative research, we aim to translate findings in the lab directly from the bench to the bedside. We are currently evaluating novel therapies for Parkinson's disease and amyotrophic lateral sclerosis (ALS). We hope that our findings will ultimately reduce morbidity and improve quality of life in those suffering from these devastating disorders.

Funding Sources